MedPath

Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia

Not Applicable
Recruiting
Conditions
Sleep Initiation and Maintenance Disorders
Interventions
Other: therapeutic education
Other: Actimetry
Registration Number
NCT05000528
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

20 to 30% of the general population suffers from chronic insomnia. Cognitive behavioral therapy (CBT) is the first-line treatment, but unfortunately its implementation is complex. Long waiting times for a consultation / exploration, too short a consultation period, non-reimbursement of specialists and a lack of trained staff make the current care of insomniac patients difficult. Patients are thus treated late, often with heavy drug treatment, dependence on sleeping pills, difficult withdrawal and / or reactive mood disorders. The treatment is therefore limited to advice on sleep hygiene and a restriction of time spent in bed without ultimately intervening in the cognitive domain. Therapeutic education consists of empowering the patient in the management of chronic insomnia through group education workshops. The patient learns the principles of normal sleep, the way in which sleep evolves with aging, the dangers of treatments as well as the rules of sleep hygiene and the behaviors to modify to sleep well. In addition to benefiting from sharing of experience with other patients, therapeutic education makes the care pathway smoother and considerably reduces the long waiting times of the traditional care pathway in consultation.

The study investigators hypothesize that therapeutic education is more effective as a treatment for chronic insomnia than traditional management in individualized consultation (IC). Thus, therapeutic education could constitute an effective alternative to CBT.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria
  • The patient must have given their free and informed consent
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient must understand and read French
  • Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score > 14/28.
Exclusion Criteria
  • Patient with cognitive impairment as assessed by the investigator
  • Patient with shift work
  • Patients scoring > 10/24 on the Epworth sleepiness scale
  • Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study.
  • Patient with chronic alcohol consumption or drug abuse
  • Patient unable to express consent.
  • Pregnant, parturient or breastfeeding patient.
  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Therapeutic educationActimetry-
Individualized consultationActimetry-
Therapeutic educationtherapeutic education-
Primary Outcome Measures
NameTimeMethod
Improvement in chronic insomnia between groupsDay 28

Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

Secondary Outcome Measures
NameTimeMethod
Change in total sleeping time between groupsDay 28

Change in total sleeping time (minutes) from inclusion

Change in time in bed between groupsDay 28

Change in time in bed (minutes) from inclusion

Change in effective sleepDay 28

Time between going to bed and falling asleep (minutes). Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet

Change in sleep latencyDay 28

% total sleeping time / time in bed. Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet

Change in intra-sleep timeDay 28

Change in time between going to bed and falling asleep (minutes) since inclusion, data collected from patient sleep agenda

Change in anxiety since baseline between groupsMonth 4

State-Trait Anxiety Inventory (STAI-Y). Self-questionnaire assessing anxiety-status (AE)

Change in depression since baseline between groupsMonth 4

Beck Depression Inventory (BDI). The total score is obtained by adding the scores of the 13 items. This score will be between 0 and 63. The higher the score, the more depressed the subject is.

Change in quality of life since baselineMonth 4

Dysfunctional Beliefs and Attitudes about Sleep - 16 (DBAS-16). This self-questionnaire is composed of 16 items: Perceived consequences of insomnia (5 items), Worry/impotence about insomnia (6 items), Sleep expectations (2 items), Medication (3 items). The global score is an average of the scores of each item, ranging from 0 to 10. The higher the score, the more dysfunctional beliefs and attitudes about sleep

Use of hypnotic drugs between groupsDay 28

Yes/no for each type

Use of anxiolytic drugs between groupsDay 28

Yes/no for each type

Dose of any hypnotic drugs taken between groupsDay 28
Dose of any anxiolytic drugs taken between groupsDay 28
Completion of therapeutic education sessions of patients in the therapeutic education groupDay 28

Yes/no

Length of workshops in the therapeutic education groupDay 28

Minutes

Problems encountered during workshops of patients in the therapeutic education groupDay 28

Descriptive list made by investigator

Patient-reported reason for refusal to participate in the therapeutic education groupDay 28

Descriptive list of reasons given by the patient

Improvement in chronic insomnia between groupsMonth 4

Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

Trial Locations

Locations (1)

CHU de NIMES

🇫🇷

Nimes, France

© Copyright 2025. All Rights Reserved by MedPath